Gynecology

Latest News



Analysis of data from more than 2.2 million vaginal deliveries shows that episiotomy declined between 2006 and 2012 and nonmedical factors may have been at play. The findings were published in a Research Letter in JAMA.

An ADP-ribose polymerase (PARP) inhibitor has received accelerated approval from the US Food and Drug Administration (FDA) for treatment of women with heavily pretreated ovarian cancer associated with defective BRCA genes.

Women at risk of ovarian cancer and who are undergoing hysterectomy should be counseled about the possible benefits of salpingectomy, according to a new committee opinion from the American College of Obstetricians and Gynecologists.

On July 29, 2010, a 46-year-old obese primarily Spanish-speaking patient was admitted to a hospital by her private ob/gyn Dr. A for a total laparoscopic hysterectomy (TLH) and/or laparoscopically assisted vaginal hysterectomy (LAVH) that day.

FDA approves Gardasil 9

On December 10, 2014, the US Food and Drug Administration (FDA) approved Gardasil 9 (Human Papillomavirus [HPV] 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by 9 types of HPV.

A California woman with a history of 2 premature deliveries and a single miscarriage became pregnant in 2004. A few days after the pregnancy was confirmed, she was seen by a physician at a military base in connection with an application to accompany her husband overseas. The application was approved and the patient went to Spain, where she delivered at 31 weeks’ gestation in 2005.

A panel of experts were bested only once at the “Stump the Professors” session at the 43rd AAGL Global Congress on Minimally Invasive Gynecology in Vancouver. A sarcoma was the diagnosis that got away among three complex cases presented to a packed audience.